Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: Washington D.C. DC, Richmond VA, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase 2, Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Washington D.C. DC, Hershey PA, Charlottesville VA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & ResponsiveNew
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
for
Venous Thromboses, Venous Disease, Venous Leg Ulcer,
Location: Washington D.C. DC, Darien CT, Dallas TX, Seattle WA
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07538609
Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Washington D.C. DC, Philadelphia PA, Allentown PA,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Washington D.C. DC, Philadelphia PA, Bethlehem PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase 3, Recruiting
Active & Responsive
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Washington D.C. DC, Hershey PA, Bethlehem PA,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase 1, Recruiting
Active & Responsive
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
for
IO Resistant Squamous and Nonsquamous NSCLC
Location: Washington D.C. DC, New York NY, Knoxville TN,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07217301
Phase 3, Recruiting
Active & Responsive
SNS and PrEP Initiation and Adherence in Black SMM
for
HIV
Location: Washington DC
Sponsor: Us Helping Us, People Into Living, Inc.
Sex: Male
Age: 18+
Code: NCT05499962
Recruiting
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: Washington D.C. DC, Philadelphia PA, New York NY,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT04038502
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
for
Opioid Use Disorder, Opioid Use Disorder, Severe,
Location: Washington D.C. DC, Greenville SC, Milwaukee WI,
Sponsor: Montefiore Medical Center
Sex: All
Age: 18+
Code: NCT07631598
Recruiting
Active & Responsive
Sensory Feedback and Hand Motor Adaptation
for
Stroke
Location: Washington D.C. DC
Sponsor: The Catholic University of America
Sex: All
Age: 20 - 70
Code: NCT07598695
Early Phase 1, Recruiting
Active & ResponsiveNew
Dietary Intervention for Migraine Relief
for
Migraine
Location: Washington D.C. DC
Sponsor: American University
Sex: All
Age: 18 - 70+
Code: NCT07360405
Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Washington D.C. DC, Rockville MD, Norfolk VA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Washington D.C. DC, Philadelphia PA, New Hyde Park NY,